Wednesday, March 30, 2016

BRIEF-Oxigene receives fast track status from U.S. FDA for CA4P

* Oxigene receives fast track designation from U.S. FDA for CA4P Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)











Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)